PVR and neoplasm: CD96 belongs to the immunoglobulin superfamily and acts as a co-inhibitory receptor that competes with the co-stimulatory receptor CD226 for the shared ligands CD155 (PVR) and CD211 (NECTIN1), both of which are expressed on tumor and myeloid cells.47